TrialDiabetes care2025

Early Fasting Serum Glucose or Weight Reduction With Tirzepatide and Metabolic Outcomes in People With Type 2 Diabetes: A Post Hoc Analysis of the SURPASS Trials.

Francesco Giorgino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.